Collective Redress
Individual businesses or consumers are often reluctant to claim
compensation for the harm caused by anticompetitive conduct. There
are many potential reasons in this respect: The damage individually
sustained might be relatively low or difficult to prove, the risks of
enforcing damage claims might be regarded too high in view of ongoing
business relationships, or a damage action appears to be too costly and
burdensome. Mechanisms of collective redress are said to overcome these
obstacles to effective private enforcement. They allow for the bundling
of a multitude of individual claims which result from the same
competition law infringement and creates significant procedural
efficiencies for the benefit of the claimants, defendants and the
judicial system as a whole.
A number of different collective redress mechanisms are discussed:
-
Representative actions
-
Opt-in collective actions
-
Opt-out class actions
-
CDC approach
Representative actions
In its White Paper, the Commission has suggested the introduction of a
representative action for damages brought by qualified entities such as
consumer associations, state bodies or trade associations which then
act on behalf of identified or, in limited cases, identifiable victims.
These entities are either officially designated in advance or certified
on an
ad hoc basis in a given case by the Member States.
It is unclear whether this approach could overcome the obstacles
to private antitrust enforcement. For example, it is far from clear
whether such ‘qualified entities’ can assume the
administrative burden of bundling a multitude of claims and of
collecting and analysing the purchase data required for the damage
calculation. The running of representative actions with potentially
millions or hundreds of thousands of claimants over several years also
requires a high level of know-how, management, and manpower. Consumer
or trade associations will usually not have the technical and IT
infrastructure as well as the resources necessary to cope with the
complexity of antitrust damage actions. The financial risks involved in
multi-party damage actions might also exceed their capacities.
Doubts about the model of representative actions have been raised by
different stakeholders in the public consultation of the Commission on
its White Paper. According to the Association of European Competition
Law Judges, for instance, the bringing of damages actions on behalf of
victims who have not yet been identified ran counter to the principle
of full compensation for those who have suffered harm, in that it could
result in damages being awarded before the alleged victims have been
identified. In some cases, it may not be possible to identify all
relevant victims who are alleged to have suffered harm.
Indeed, it is not clear how full recovery of the damages suffered can
be ensured by a representative action. For example, the UK’s
leading consumer association
Which?, the only organisation in the UK
with government-granted power to represent consumers in antitrust
damages actions, sought compensation from
JJB Sports,
alleging that, along with its rivals, the company had fixed prices on
replica football shirts between 2000 and 2001. In a settlement reached
in 2008,
JJB agreed to pay £ 20 a shirt to each consumer affected. However, in spite of an extensive media campaign,
Which? managed to collect only about 600 consumers who had purchased one or more of the shirts concerned, According to
Which?, this was only a very small minority of the total number of consumers who were harmed by
JJB’s price-fixing. In this case, the efforts made in the course of the proceedings were barely justified.
Opt-in collective actions
A further collective redress mechanism proposed by the Commission is
the opt-in collective action. Under this approach victims expressly
decide to combine their individual claims for harm they suffered into
one single action.
The opt-in collective action seems to be, in principle, the most
suitable form of collective redress. In particular, the approach is
in line with the European legal culture and traditions. The opt-in
collective action offers, however, no effective solution for the
special requirements in antitrust damage actions. Each claimant would
be a party to the legal proceedings and would thus have to substantiate
and evidence the individual damage caused by the cartel. The claimants
would also have to bear the costs and financial risks of the antitrust
damage action. However, small and medium-sized corporate victims in
particular, for whom the opt-in collective action is notably designed
for, are often unwilling to bear the considerable costs
and risks associated with antitrust litigation.
Opt-out class actions
Class actions are a procedural tool which enables one or more plaintiff
members of a certain class of victims to sue cartel members on behalf
of all similarly situated members of the same class. Following the
certification of such a class by the court every class member can,
however, declare his ‘opt out’ from the class, and thus the
proceedings. All class members who within a certain time period do not
expressly opt out are bound by the court decision in the case.
Contrary to the United States, where this type of class action system
was originally developed, most European countries do not recognise
class actions as an appropriate mechanism for enforcing private
antitrust claims. In particular the fact that all cartel victims, along
with their damage claims, are automatically included in a class and
thus party to court proceedings unless they do not explicitly opt-out
seems contradictory to fundamental principles of civil procedure in
Europe.
CDC approach
CDC usually purchases a multitude of individual antitrust damage
claims, evaluates the cartel-related damage on a market-wide basis, and
enforces the claims in its own name and on its own account (see
Approach).
CDC thus provides a model of private enforcement of competition law,
which is in line with existing legal principles in Europe and allows
for an effective enforcement of cartel-related damage claims. It shows
how antitrust damage claims can collectively be enforced today, without
the introduction of new procedural tools and in a different way from
the muchcriticised US class action system. Rather, the CDC approach is
based on the perception of antitrust damage claims as valuable and
marketable assets. This approach is directly rooted in the market and
thus corresponds to the demands of an effective private antitrust
enforcement in practice. The bundling of claims by CDC on a material law level creates
synergies and economies of scale as regards the economic analysis of
the cartel-related damage and the enforcement of claims.
Printer friendly version of this page 
CDC · Avenue Louise 475 · B-1050 Brussels · Tel: +32 (0) 2 213 49 20